P056 Oral Ibrexafungerp outcomes by fungal disease in patients from an interim analysis of a Phase 3 Open-label Study (FURI)
P056 口服 Ibrexafungerp 治疗真菌病患者的疗效(来自一项 3 期开放标签研究 (FURI) 的中期分析)
期刊:Journal of Clinical Microbiology
影响因子:5.4
doi:10.1128/JCM.00393-11
Espinel-Ingroff, A; Canton, E; Fothergill, A; Ghannoum, M; Johnson, E; Jones, R N; Ostrosky-Zeichner, L; Schell, W; Gibbs, D L; Wang, A; Turnidge, J; Kermani, Firoozeh; Taghizadeh‐Armaki, Mojtaba; Hosseini, Seyed Abdollah; Amirrajab, Nasrin; Javidnia, Javad; Zaghrami, Mahmoud Fami; Shokohi, Tahereh; Nasri, Elahe; Fakhim, Hamed; Vaezi, Afsane; Mirhendi, Hossein; Rizi, Mahnaz Hosseini; Shelerangkon, Mahsa; Ghafel, Safiyeh; Badali, Hamid; Ghazanfari, Sahar; mohammadi, Shahla Roudbar; Rezaei, Sasan; Prattes, Juergen; King, Thomas; Azie, Nkechi; Angulo, David